T0	Participants 85 108	small cell lung cancer]
T1	Participants 111 160	Eighty-three patients with small cell lung cancer
T2	Participants 347 388	74 patients were availble to be analysis.
T3	Participants 419 474	well-matched in age, sex, stage and performance status.
T4	Participants 1590 1611	solid cancer patients